CASI Pharma (CASI) Reports Q3 Loss of $0.05
CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.05), versus ($0.07) reported last year.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.05), versus ($0.07) reported last year.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.